(NASDAQ: EMBC) Embecta's forecast annual revenue growth rate of 0.15% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.37%.
Embecta's revenue in 2025 is $1,107,700,000.On average, 1 Wall Street analysts forecast EMBC's revenue for 2025 to be $63,431,062,282, with the lowest EMBC revenue forecast at $63,431,062,282, and the highest EMBC revenue forecast at $63,431,062,282. On average, 1 Wall Street analysts forecast EMBC's revenue for 2026 to be $64,326,332,565, with the lowest EMBC revenue forecast at $64,326,332,565, and the highest EMBC revenue forecast at $64,326,332,565.
In 2027, EMBC is forecast to generate $64,570,497,188 in revenue, with the lowest revenue forecast at $64,570,497,188 and the highest revenue forecast at $64,570,497,188.